Table 1.
Overview of cardiomyocytes force measurements
Donor | |||||
---|---|---|---|---|---|
Incubation | Fmax | pCa50 | ΔpCa50 | nH | Ktr |
Control | 5 donor hearts; 13 myocytes | ||||
Basal | 26.8±3.8 | 5.43±0.03 | 2.7±0.2 | 0.67±0.07 | |
After PKA | 24.8±3.7 | 5.40±0.03 | 0.03±0.01 | 2.6±0.2* | 0.92±0.10* |
cTn [0.5mg/ml] | 5 donor hearts; 19 myocytes | ||||
Basal | 26.7±3.2 | 5.55±0.02 | 2.9±0.2 | 0.66±0.05 | |
After PKA | 23.1±2.5* | 5.46±0.02* | 0.10±0.01 | 2.8±0.2 | 0.69±0.04 |
cTn [1.0mg/ml] | 5 donor hearts; 14 myocytes | ||||
Basal | 21.1±3.2 | 5.50±0.02 | 2.6±0.2 | 0.64±0.03 | |
After PKA | 20.0±3.0 | 5.41±0.02* | 0.10±0.01 | 2.8±0.3 | 0.62±0.05 |
Failing | |||||
Incubation | Fmax | pCa50 | ΔpCa50 | nH | Ktr |
Control | 5 failing hearts; 15 myocytes | ||||
Basal | 31.5±3.8 | 5.60±0.01 | 3.6±0.3 | 0.59±0.04 | |
After PKA | 30.1±4.0 | 5.50±0.01* | 0.10±0.01 | 3.9±0.3 | 0.75±0.10 |
cTn+P [0.5mg/ml] | 5 failing hearts; 18 myocytes | ||||
Basal | 21.4±1.6 | 5.57±0.02 | 2.9±0.1 | 0.65±0.06 | |
After PKA | 18.4±1.5* | 5.44±0.02* | 0.13±0.01 | 2.9±0.1 | 0.66±0.06 |
cTn+P [1.0mg/ml] | 5 failing hearts; 17 myocytes | ||||
Basal | 20.9±2.3 | 5.60±0.02* | 3.3±0.2 | 0.71±0.10 | |
After PKA | 20.1±2.0 | 5.48±0.02 | 0.12±0.02 | 3.3±0.3 | 0.64±0.04 |
Control denotes results obtained from cardiomyocytes kept in exchange buffer without cTn complex added. Abbreviations: Fmax, maximal force at saturating calcium concentration in kN/m2; pCa50 and nH, midpoint and steepness of the force-pCa curves, respectively; Ktr, rate of tension redevelopment (s−1) at saturating calcium concentration.
P<0.05, effect of PKA in paired t-test.